75 related articles for article (PubMed ID: 7816293)
1. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa.
Frenken LA; van Lier HJ; Koene RA
Nephrol Dial Transplant; 1994; 9(9):1295-8. PubMed ID: 7816293
[TBL] [Abstract][Full Text] [Related]
2. Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection.
Frenken LA; van Lier HJ; Jordans JG; Leunissen KM; van Leusen R; Verstappen VM; Koene RA
Am J Kidney Dis; 1993 Oct; 22(4):553-6. PubMed ID: 8213795
[TBL] [Abstract][Full Text] [Related]
3. Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta.
Veys N; Dhondt A; Lameire N
Clin Nephrol; 1998 Jan; 49(1):41-4. PubMed ID: 9491285
[TBL] [Abstract][Full Text] [Related]
4. Pain after subcutaneous injection of recombinant human erythropoietin: does Emla cream help?
Morris KP; Hughes C; Hardy SP; Matthews JN; Coulthard MG
Nephrol Dial Transplant; 1994; 9(9):1299-301. PubMed ID: 7816294
[TBL] [Abstract][Full Text] [Related]
5. Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study.
Granolleras C; Leskopf W; Shaldon S; Fourcade J
Clin Nephrol; 1991 Dec; 36(6):294-8. PubMed ID: 1769141
[TBL] [Abstract][Full Text] [Related]
6. A trial comparing local pain after subcutaneous injection of epoetin-beta versus darbepoetin-alpha in healthy volunteers.
Berthoux F; Ryckelynck JP; Rouanet S; Gelu-Mantoulet S; Montestruc F; Mouchel P; Choukroun G;
Clin Nephrol; 2008 Jul; 70(1):33-40. PubMed ID: 18793546
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
9. Pain comparison after subcutaneous administration of single-dose formulation versus multidose formulation of epogen in hemodialysis patients.
St Peter WL; Lewis MJ; Macres MG
Am J Kidney Dis; 1998 Sep; 32(3):470-4. PubMed ID: 9740164
[TBL] [Abstract][Full Text] [Related]
10. Nebulized bacteriostatic saline as a cause of bronchitis.
Reynolds RD; Smith RM
J Fam Pract; 1995 Jan; 40(1):35-40. PubMed ID: 7807035
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the pharmacokinetics of two recombinant human erythropoietin preparations: epoetin zeta and epoetin alfa. 2nd Communication: A monocentric, double-blind, randomized, single dose, three-period crossover trial in healthy volunteers.
Kirkov V; Dimitrova V; Siebert-Weigel M; Wolf-Pflugmann M; Koytchev R; Richter W; Bronn A; Arsova S; Kromminga A
Arzneimittelforschung; 2008; 58(5):220-4. PubMed ID: 18589556
[TBL] [Abstract][Full Text] [Related]
12. Painless subcutaneous erythropoietin (rHuEpo) injection--is it the panacea?
Hörl WH
Nephrol Dial Transplant; 1994; 9(9):1224-5. PubMed ID: 7816279
[No Abstract] [Full Text] [Related]
13. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
[TBL] [Abstract][Full Text] [Related]
14. Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial.
Yelland MJ; Glasziou PP; Bogduk N; Schluter PJ; McKernon M
Spine (Phila Pa 1976); 2004 Jan; 29(1):9-16; discussion 16. PubMed ID: 14699269
[TBL] [Abstract][Full Text] [Related]
15. Intradermal bacteriostatic 0.9% sodium chloride containing the preservative benzyl alcohol compared with intradermal lidocaine hydrochloride 1% for attenuation of intravenous cannulation pain.
McNelis KA
AANA J; 1998 Dec; 66(6):583-5. PubMed ID: 10488265
[TBL] [Abstract][Full Text] [Related]
16. Pain perception after subcutaneous injections of media containing different buffers.
Laursen T; Hansen B; Fisker S
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):218-21. PubMed ID: 16445598
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous sterile water injection for labour pain: a randomised controlled trial.
Bahasadri S; Ahmadi-Abhari S; Dehghani-Nik M; Habibi GR
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):102-6. PubMed ID: 16638030
[TBL] [Abstract][Full Text] [Related]
18. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin response to subcutaneous versus intravenous epoetin alfa administration in iron-replete haemodialysis patients.
Leikis MJ; Kent AB; Becker GJ; McMahon LP
Nephrology (Carlton); 2004 Jun; 9(3):153-60. PubMed ID: 15189176
[TBL] [Abstract][Full Text] [Related]
20. Does dexmedetomidine reduce the injection pain due to propofol and rocuronium?
Ayoğlu H; Altunkaya H; Ozer Y; Yapakçi O; Cukdar G; Ozkoçak I
Eur J Anaesthesiol; 2007 Jun; 24(6):541-5. PubMed ID: 17241503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
